Shared by
beno
Fundamentals
N/a
Catalysts / News / Painting the picture
-Corona virus sympathy
-Health officials say virus vaccine development has 'no glitches'
-Feb 11 2020: $500m IPO @ $19 per share
-mRNA-1273 coronavirus vaccine sent for testing
-March 16 2020: First human trial of COVID-19 vaccine
Technical Analysis
-Intraday pattern: Mountain
-Levels: 27.50, 29, 30, 31, 32.50
Original Plan / Strategy
FT-15 long of 27.50 level with half dollar confluence
Review
OGT. Only got filled two lots but they were bottom ticks, didn't want to chase as spread was bad. Slowly scaled out 10 shares at a time taking advantage of better and better prices
Execution detail:
| Date/time | Symbol | Side | Price | Position |
|---|---|---|---|---|
| 2020-03-17 13:28:43 | MRNA | buy | $27.630 | long |
| 2020-03-17 13:29:04 | MRNA | buy | $27.660 | long |
| 2020-03-17 13:29:27 | MRNA | sell | $28.100 | long |
| 2020-03-17 13:29:35 | MRNA | sell | $28.190 | long |
| 2020-03-17 13:29:46 | MRNA | sell | $28.150 | long |
| 2020-03-17 13:30:43 | MRNA | sell | $28.180 | long |
| 2020-03-17 13:31:17 | MRNA | sell | $28.300 | long |
| 2020-03-17 13:31:22 | MRNA | sell | $28.350 | long |
| 2020-03-17 13:31:24 | MRNA | sell | $28.470 | long |
| 2020-03-17 13:31:50 | MRNA | sell | $27.950 | 0 |
Leave a comment about this trade!
You need to log into your Tradervue account to leave a comment. If you don't have one,
it takes
just a few seconds to sign up, and it's free!